|
1
|
Malek M and Nematbakhsh M: Renal
ischemia/reperfusion injury; From pathophysiology to treatment. J
Renal Inj Prev. 4:2655–27. 2015.
|
|
2
|
Kellum JA, Unruh ML and Murugan R: Acute
kidney injury. BMJ Clin Evid. 2011:20012011.PubMed/NCBI
|
|
3
|
Sethi K, Rao K, Bolton D, Patel O and
Ischia J: Targeting HIF-1α to prevent renal ischemia-reperfusion
injury: Does it work? Int J Cell Biol. 2018:98527912018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Guo Z, Yu S, Chen X, Ye R, Zhu W and Liu
X: NLRP3 is involved in ischemia/reperfusion injury. CNS Neurol
Disord Drug Targets. 15:699–712. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Minutoli L, Puzzolo D, Rinaldi M, Irrera
N, Marini H, Arcoraci V, Bitto A, Crea G, Pisani A, Squadrito F, et
al: ROS-mediated NLRP3 inflammasome activation in brain, heart,
kidney, and testis ischemia/reperfusion injury. Oxid Med Cell
Longev. 2016:21830262016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Shao BZ, Xu ZQ, Han BZ, Su DF and Liu C:
NLRP3 inflammasome and its inhibitors: A review. Front Pharmacol.
6:2622015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Latz E: The inflammasomes: Mechanisms of
activation and function. Curr Opin Immunol. 22:28–33. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Mezzaroma E, Toldo S, Farkas D, Seropian
IM, Tassell BW, Salloum FN, Kannan HR, Menna AC, Voelkel NF and
Abbate A: The inflammasome promotes adverse cardiac remodeling
following acute myocardial infarction in the mouse. Proc Natl Acad
Sci USA. 108:19725–19730. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sandanger Ø, Ranheim T, Vinge LE, Bliksøen
M, Alfsnes K, Finsen AV, Dahl CP, Askevold ET, Florholmen G,
Christensen G, et al: The NLRP3 inflammasome is up-regulated in
cardiac fibroblasts and mediates myocardial ischemia-reperfusion
injury. Cardiovasc Res. 99:164–174. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Xin R, Sun X, Wang Z, Yuan W, Jiang W,
Wang L, Xiang Y, Zhang H, Li X, Hou Y, et al: Apocynin inhibited
NLRP3/XIAP signalling to alleviate renal fibrotic injury in rat
diabetic nephropathy. Biomed Pharmacother. 106:1325–1331. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hou Y, Lin S, Qiu J, Sun W, Dong M, Xiang
Y, Wang L and Du P: NLRP3 inflammasome negatively regulates
podocyte autophagy in diabetic nephropathy. Biochem Biophys Res
Commun. 521:791–798. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wu R, Liu X, Yin J, Wu H, Cai X, Wang N,
Qian Y and Wang F: IL-6 receptor blockade ameliorates diabetic
nephropathy via inhibiting inflammasome in mice. Metabolism.
83:18–24. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang F, Yin J, Lin Y, Zhang F, Liu X,
Zhang G, Kong Y, Lu Z, Wu R, Wang N, et al: IL-17C has a pathogenic
role in kidney ischemia/reperfusion injury. Kidney Int.
97:1219–1229. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wen Y, Liu YR, Tang TT, Pan MM, Xu SC, Ma
KL, Lv LL, Liu H and Liu BC: mROS-TXNIP axis activates NLRP3
inflammasome to mediate renal injury during ischemic AKI. Int J
Biochem Cell Biol. 98:43–53. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Nangaku M and Eckardt KU: Hypoxia and the
HIF system in kidney disease. J Mol Med (Berl). 85:1325–1330. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Batie M, Druker J, D'Ignazio L and Rocha
S: KDM2 family members are regulated by HIF-1 in hypoxia. Cells.
6:82017. View Article : Google Scholar
|
|
17
|
Ichimura T, Bonventre JV, Bailly V, Wei H,
Hession CA, Cate RL and Sanicola M: Kidney injury molecule-1
(KIM-1), a putative epithelial cell adhesion molecule containing a
novel immunoglobulin domain, is up-regulated in renal cells after
injury. J Biol Chem. 273:4135–4142. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lv L, Jiang SS, Xu J, Gong JB and Cheng Y:
Protective effect of ligustrazine against myocardial ischaemia
reperfusion in rats: The role of endothelial nitric oxide synthase.
Clin Exp Pharmacol Physiol. 39:20–27. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chen HY, Xu DP, Tan GL, Cai W, Zhang GX,
Cui W, Wang JZ, Long C, Sun YW, Yu P, et al: A potent
multi-functional neuroprotective derivative of tetramethylpyrazine.
J Mol Neurosci. 56:977–987. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Tuttle RS, Marmelstein L, Trad T, Reddy S
and Radley T: In vitro uterine response to tetramethylpyrazine, the
active constituent of Chung Chong (a traditional Chinese medicine).
Am J Obstet Gynecol. 161:1319–1323. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yang WJ, Li YR, Gao H, Wu XY, Wang XL,
Wang XN, Xiang L, Ren DM, Lou HX and Shen T: Protective effect of
the ethanol extract from Ligusticum chuanxiong rhizome against
streptozotocin-induced diabetic nephropathy in mice. J
Ethnopharmacol. 227:166–175. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Luan Y, Liu J, Liu X, Xue X, Kong F, Sun
C, Wang J, Liu L and Jia H: Tetramethypyrazine inhibits renal cell
carcinoma cells through inhibition of NKG2D signaling pathways. Int
J Oncol. 49:1704–1712. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Jiang G, Xin R, Yuan W, Zhang L, Meng X,
Sun W, Han H, Hou Y, Wang L and Du P: Ligustrazine ameliorates
acute kidney injury through downregulation of NOD2-mediated
inflammation. Int J Mol Med. 45:731–742. 2020.PubMed/NCBI
|
|
24
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Guo M, Liu Y and Shi D: Cardiovascular
actions and therapeutic potential of tetramethylpyrazine (active
component isolated from rhizoma chuanxiong): Roles and mechanisms.
Biomed Res Int. 2016:24303292016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zheng Q, Huang YY, Zhu PC, Tong Q, Bao XY,
Zhang QH, Zheng GQ and Wang Y: Ligustrazine exerts cardioprotection
in animal models of myocardial ischemia/reperfusion injury:
Preclinical evidence and possible mechanisms. Front Pharmacol.
9:7292018. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Mehrotra P, Sturek M, Neyra JA and Basile
DP: Calcium channel Orai1 promotes lymphocyte IL-17 expression and
progressive kidney injury. J Clin Invest. 129:4951–4961. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kar F, Hacioglu C, Senturk H, Donmez DB
and Kanbak G: The role of oxidative stress, renal inflammation, and
apoptosis in post ischemic reperfusion injury of kidney tissue: The
protective effect of dose-dependent boric acid administration. Biol
Trace Elem Res. 195:150–158. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chen B, Ma Y, Xue X, Wei J, Hu G and Lin
Y: Tetramethylpyrazine reduces inflammation in the livers of mice
fed a high fat diet. Mol Med Rep. 19:2561–2568. 2019.PubMed/NCBI
|
|
30
|
Bai XY, Wang XF, Zhang LS, Du PC, Cao Z
and Hou Y: Tetramethylpyrazine ameliorates experimental autoimmune
encephalomyelitis by modulating the inflammatory response. Biochem
Biophys Res Commun. 503:1968–1972. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Feng L, Ke N, Cheng F, Guo Y, Li S, Li Q
and Li Y: The protective mechanism of ligustrazine against renal
ischemia/reperfusion injury. J Surg Res. 166:298–305. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Qing L, Wu P, Zhou Z, Yu F and Tang J:
Tetramethylpyrazine improved the survival of multiterritory
perforator flaps by inducing angiogenesis and suppressing apoptosis
via the Akt/Nrf2 pathway. Drug Des Devel Ther. 13:1437–1447. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zhang F, Jin H, Wu L, Shao J, Wu X, Lu Y
and Zheng S: Ligustrazine disrupts lipopolysaccharide-activated
NLRP3 inflammasome pathway associated with inhibition of Toll-like
receptor 4 in hepatocytes. Biomed Pharmacother. 78:204–209. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wu X, Zhang F, Xiong X, Lu C, Lian N, Lu Y
and Zheng S: Tetramethylpyrazine reduces inflammation in liver
fibrosis and inhibits inflammatory cytokine expression in hepatic
stellate cells by modulating NLRP3 inflammasome pathway. IUBMB
Life. 67:312–321. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Huang X, Zuo L, Lv Y, Chen C, Yang Y, Xin
H, Li Y and Qian Y: Asiatic acid attenuates myocardial
ischemia/reperfusion injury via Akt/GSK-3β/HIF-1α signaling in rat
H9c2 cardiomyocytes. Molecules. 21:12482016. View Article : Google Scholar
|
|
36
|
Nicholas SA, Bubnov VV, Yasinska IM and
Sumbayev VV: Involvement of xanthine oxidase and hypoxia-inducible
factor 1 in Toll-like receptor 7/8-mediated activation of caspase 1
and interleukin-1β. Cell Mol Life Sci. 68:151–158. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Ouyang X, Ghani A, Malik A, Wilder T,
Colegio OR, Flavell RA, Cronstein BN and Mehal WZ: Adenosine is
required for sustained inflammasome activation via the
A2A receptor and the HIF-1α pathway. Nat Commun. 4:2909.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Cosin-Roger J, Simmen S, Melhem H, Atrott
K, Frey-Wagner I, Hausmann M, de Vallière C, Spalinger MR,
Spielmann P, Wenger RH, et al: Hypoxia ameliorates intestinal
inflammation through NLRP3/mTOR downregulation and autophagy
activation. Nat Commun. 8:982017. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Sokulsky LA, Goggins B, Sherwin S, Eyers
F, Kaiko GE, Board PG, Keely S, Yang M and Foster PS: GSTO1-1 is an
upstream suppressor of M2 macrophage skewing and HIF-1α-induced
eosinophilic airway inflammation. Clin Exp Allergy. 50:609–624.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Hernández A, Geng Y, Sepúlveda R, Solís N,
Torres J, Arab JP, Barrera F, Cabrera D, Moshage H and Arrese M:
Chemical hypoxia induces pro-inflammatory signals in fat-laden
hepatocytes and contributes to cellular crosstalk with Kupffer
cells through extracellular vesicles. Biochim Biophys Acta Mol
Basis Dis. 1866:1657532020. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Tang TT, Lv LL, Pan MM, Wen Y, Wang B, Li
ZL, Wu M, Wang FM, Crowley SD and Liu BC: Hydroxychloroquine
attenuates renal ischemia/reperfusion injury by inhibiting
cathepsin mediated NLRP3 inflammasome activation. Cell Death Dis.
9:3512018. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Liang S, Xu Z, Ruan Y, Niu T, Guo W, Jiang
W and Hou J: Isoquercitrin attenuates renal ischemia/reperfusion
injury through antioxidation, anti-inflammation, and antiapoptosis
in mice. Transplant Proc. 52:1014–1019. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Han F, Dou M, Wang Y, Xu C, Li Y, Ding X,
Xue W, Zheng J, Tian P and Ding C: Cordycepin protects renal
ischemia/reperfusion injury through regulating inflammation,
apoptosis, and oxidative stress. Acta Biochim Biophys Sin
(Shanghai). 52:125–132. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Yang F, Wang Z, Wei X, Han H, Meng X,
Zhang Y, Shi W, Li F, Xin T, Pang Q and Yi F: NLRP3 deficiency
ameliorates neurovascular damage in experimental ischemic stroke. J
Cereb Blood Flow Metab. 34:660–667. 2014. View Article : Google Scholar : PubMed/NCBI
|
